Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation: Protocol of a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial

NCT06308952 is registered in ClinicalTrials.gov with Duan Chuanzhi as lead sponsor.

NCT NCT06308952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06308952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation: Protocol of a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Duan Chuanzhi
Phase
Phase 4
Overall status
Recruiting
Start date
July 30, 2024
Completion date
December 31, 2027
Enrollment
354 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular event, death, brain, endothelial dysfunction, hemorrhagic stroke, ischemic stroke, stent stenosis, stent thrombosis